Medicure Inc. (OTCMKTS:MCUJF) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.09 and traded as low as $3.30. Medicure shares last traded at $3.30, with a volume of 966 shares.
The firm’s 50 day moving average price is $3.42 and its two-hundred day moving average price is $4.08.
Medicure Company Profile (OTCMKTS:MCUJF)
Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome.
Featured Story: Why do corrections happen?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.